Jing Rong
Direktor/Vorstandsmitglied bei Cmbi Capital Management Shenzhen Co. Ltd.
Profil
Jing Rong is currently an Executive Director at Cmbi Capital Management Shenzhen Co. Ltd.
Prior to this, he worked as a Director at EpimAb Biotherapeutics, Inc. and as a Director at Burning Rock Biotech Ltd.
from 2017 to 2022.
He also served as Vice President-Investment Funds at China Merchants Capital Management Co., Ltd.
from 2012 to 2015.
Mr. Rong holds an MBA from The Chinese University of Hong Kong, which he earned in 2012, and an undergraduate degree from Xiamen University, which he earned in 2003.
Aktive Positionen von Jing Rong
| Unternehmen | Position | Beginn |
|---|---|---|
| Cmbi Capital Management Shenzhen Co. Ltd. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Jing Rong
| Unternehmen | Position | Ende |
|---|---|---|
| BURNING ROCK BIOTECH LIMITED | Direktor/Vorstandsmitglied | 24.06.2022 |
China Merchants Capital Management Co., Ltd.
 China Merchants Capital Management Co., Ltd. Investment ManagersFinance China Merchants Capital Management Co., Ltd. engages in the management of equity investment. It also involves in investment consulting activities. The company was founded on June 20, 2012 and is headquartered in Shenzhen, China. | Corporate Officer/Principal | 01.01.2015 |
EpimAb Biotherapeutics, Inc.
 EpimAb Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology EpimAb Biotherapeutics, Inc. is a Chinese clinical stage biopharmaceutical company that specializes in developing multispecific antibodies. The company is based in Shanghai, China. The company utilizes its in-house research and technology capabilities, including the proprietary fit-ig® and mat-fab bispecific platforms, to generate and advance a unique pipeline of transformative preclinical and clinical assets that aim to benefit cancer patients. The company was founded in 2016 by Chen Bing Wu, who has been the CEO since 2016. | Direktor/Vorstandsmitglied | - |
Ausbildung von Jing Rong
| The Chinese University of Hong Kong | Masters Business Admin |
| Xiamen University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| BURNING ROCK BIOTECH LIMITED | Health Services |
| Private Unternehmen | 3 |
|---|---|
EpimAb Biotherapeutics, Inc.
EpimAb Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology EpimAb Biotherapeutics, Inc. is a Chinese clinical stage biopharmaceutical company that specializes in developing multispecific antibodies. The company is based in Shanghai, China. The company utilizes its in-house research and technology capabilities, including the proprietary fit-ig® and mat-fab bispecific platforms, to generate and advance a unique pipeline of transformative preclinical and clinical assets that aim to benefit cancer patients. The company was founded in 2016 by Chen Bing Wu, who has been the CEO since 2016. | Health Technology |
China Merchants Capital Management Co., Ltd.
China Merchants Capital Management Co., Ltd. Investment ManagersFinance China Merchants Capital Management Co., Ltd. engages in the management of equity investment. It also involves in investment consulting activities. The company was founded on June 20, 2012 and is headquartered in Shenzhen, China. | Finance |
| Cmbi Capital Management Shenzhen Co. Ltd. |
